Preferred
(EDT)
Other
Novel Therapeutic Strategies
Have GWAS Helped Classify Diabetes?
10:00 AM - 10:25 AM EST
Wednesday, February 3, 2021Room: V200 - Craig Speaker
Jose Florez, MD, PhD
Massachusetts General Hospital
Novel Therapeutic Strategies
Subclassifying Diabetes by Combining GWAS and Clinical Phenotyping
10:25 AM - 10:50 AM EST
Wednesday, February 3, 2021Room: V200 - Craig Speaker
Emma Ahlqvist, PhD
Lund University
Novel Therapeutic Strategies
Precision Medicine in Obesity and Diabetes
10:50 AM - 11:15 AM EST
Wednesday, February 3, 2021Room: V200 - Craig Speaker
Paul Franks, PhD
Lund University
Novel Therapeutic Strategies
Coffee Break
11:15 AM - 11:30 AM EST
Wednesday, February 3, 2021Novel Therapeutic Strategies
Mechanisms of Therapies for T2D and Potential Crossover to T1D
11:30 AM - 11:55 AM EST
Wednesday, February 3, 2021Room: V300 - Ian Speaker
Rory McCrimmon, MD
University of Dundee
Novel Therapeutic Strategies
Therapies to Stop T1D…Determining Risk and Conducting Trials
11:55 AM - 12:20 PM EST
Wednesday, February 3, 2021Room: V300 - Ian Speaker
Carla Greenbaum, MD
Benaroya Research Institute at Virginia Mason
Novel Therapeutic Strategies
Stem Cell Mediated Treatments for Diabetes
12:20 PM - 12:45 PM EST
Wednesday, February 3, 2021Room: V300 - Ian Speaker
Allan Ertmann Karlsen, PhD
Novo Nordisk
Novel Therapeutic Strategies
